DaVitaDVA
Buy moreBuy more on a dip to our buy price, which is under today's $177.
- 5 good· Earnings beat
- 6 to watch· Profit falling
$176.80−6.70 (−3.65%)
Price at 3:00 PM ET
After hours · opens in 17h 23mNext open: Friday, Nov 13, 9:30 AM ETNYSE · Healthcare · Health Care Services · Large company
The price we'd buy DVA at comes with a free account
It also has the whole brief, the scorecard and how the call has moved.A free account gets it on three stocks you pick, plus three long research reports a month.
What would change it
Sources
- From the 10-Q for the quarter to Sep 30, reported Oct 29
- Yahoo Finance daily closes to Nov 11
Any one could move it to Keep
Next report
Shrinking
sales
Compared with the S&P 500
10 points
worse in one day
23 points
worse in five trading days
+44.6% in a yearsince Nov 11, 2025
The news behind our call
DaVita is expected to grow profit meaningfully next year.
DaVita’s top quantitative ranking reflects favorable business measures and recent performance.
Broad participation across healthcare stocks gives DaVita a supportive sector backdrop.
What changed
Overview
In plain numbers
- Revenue grew 6.4% from a year earlier, to $14.2B in the last twelve months.
- It keeps 15 cents of every revenue dollar as operating profit.
- It turned 9.1% of revenue into free cash flow: $1.3B in the last twelve months.
- It owes $13.4B and holds $566.3M in cash and investments, so net debt is $12.8B.
Key figures
- Revenue (TTM)
- $14.2B
- Revenue growth, 1 year
- +6.4%
- Net income
- $920M
- EPS (diluted)
- $13.55
- Gross margin
- 32.3%
- Operating margin
- 15.2%
- Return on equity
- 96.8%
- Return on capital
- 12.2%
- Debt / equity
- 11.90
- Current ratio
- 1.41
- Buyback yield
- 14.08%
Key facts
- Company value
- $12.0B
- Price / last year's earnings
- 22.9×
- Today's range
- 176.12181.96
- Past year's range
- 103.87240.96
- Yesterday's close
- $183.50
- Swings vs the market
- 0.9×about the same